To complicate the matter, ghrelin infusion enhances somatotroph secretion and causes marked hyperglycemia coupled with a slight decrease in insulin level persisting for 2 h and inhibition of lipolysis, suggesting some non-GH-mediated effect on glucose [122]. The gene discussed is GH1; the disease is Hyperglycemia.